Fri, February 24, 2017
Thu, February 23, 2017
Wed, February 22, 2017
Tue, February 21, 2017
Mon, February 20, 2017
Fri, February 17, 2017
Thu, February 16, 2017
Wed, February 15, 2017
Tue, February 14, 2017

David Nierengarten Initiated (ANAB) at Buy and Held Target at $28 on, Feb 21st, 2017


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. -buy-and-held-target-at-28-on-feb-21st-2017.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Nierengarten of Wedbush, Initiated "AnaptysBio, Inc." (ANAB) at Buy and Held Target at $28 on, Feb 21st, 2017.

David, nor any peers, have made any analyst calls on ANAB in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Publication Contributing Sources